Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · IEX Real-Time Price · USD
32.76
+1.27 (4.03%)
Apr 29, 2024, 4:00 PM EDT - Market closed
Agios Pharmaceuticals Employees
Agios Pharmaceuticals had 386 employees on December 31, 2023. The number of employees decreased by 7 or -1.78% compared to the previous year.
Employees
386
Change (1Y)
-7
Growth (1Y)
-1.78%
Revenue / Employee
$69,490
Profits / Employee
-$912,145
Market Cap
1.82B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 386 | -7 | -1.78% |
Dec 31, 2022 | 393 | 1 | 0.26% |
Dec 31, 2021 | 392 | -170 | -30.25% |
Dec 31, 2020 | 562 | 26 | 4.85% |
Dec 31, 2019 | 536 | 54 | 11.20% |
Dec 31, 2018 | 482 | 100 | 26.18% |
Dec 31, 2017 | 382 | 95 | 33.10% |
Dec 31, 2016 | 287 | 79 | 37.98% |
Dec 31, 2015 | 208 | 80 | 62.50% |
Dec 31, 2014 | 128 | 32 | 33.33% |
Dec 31, 2013 | 96 | 12 | 14.29% |
Dec 31, 2012 | 84 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
Amneal Pharmaceuticals | 7,700 |
Evotec SE | 4,952 |
Twist Bioscience | 919 |
Beam Therapeutics | 507 |
Recursion Pharmaceuticals | 500 |
Syndax Pharmaceuticals | 184 |
Structure Therapeutics | 93 |
AGIO News
- 11 days ago - Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024 - GlobeNewsWire
- 7 weeks ago - Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024 - GlobeNewsWire
- 2 months ago - Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024 - GlobeNewsWire
- 2 months ago - Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights - GlobeNewsWire
- 3 months ago - Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024 - GlobeNewsWire
- 4 months ago - Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio - GlobeNewsWire
- 4 months ago - Agios Pharma's stock soars 19.6% on news of positive results in trial of treatment for rare blood disorder - Market Watch
- 4 months ago - Agios' blood disorder drug meets goals of late-stage study - Reuters